Investor Overview

NASDAQ: XBIT0.1815.61Data provided by Nasdaq.
Minimum 15 minutes delayed.

XBiotech is building on a foundation of remarkable new therapies, innovative approaches to commercialization and a commitment to realizing treatments for unmet medical needs worldwide.

Recent News
10/12/16XBiotech Announces Successful Completion of EMA GMP InspectionPrinter Friendly Version
10/11/16XBiotech Announces Dismissal of Class Action Lawsuit in TexasPrinter Friendly Version
08/22/16XBiotech Announces Grand Opening Date for New Commercial Manufacturing FacilityPrinter Friendly Version

Read more »

Upcoming Events

There are currently no events scheduled.

Read more »